National
After action on immigration, will Obama move to protect LGBT workers?
White House says no executive order ‘at this time’
President Obama’s action last week protecting many young, undocumented immigrants from deportation has won praise in progressive circles — including among LGBT advocates — but the move raises a question: Can the LGBT community now expect that the previously denied administrative actions they’ve been seeking will come to fruition?
On Friday, the Obama administration announced that an estimated 800,000 young undocumented immigrants who were brought into the United States will be considered for relief from removal from the country if they meet certain criteria. Among the criteria is whether the person in question has a college education or has served in the military. Those criteria would have protected such immigrants from deportation had Congress passed the DREAM Act.
During remarks in the White House Rose Garden, Obama announced the policy change and said it was a means to keep talented people in the United States.
“As I said in my speech on the economy yesterday, it makes no sense to expel talented young people, who, for all intents and purposes, are Americans — they’ve been raised as Americans; understand themselves to be part of this country — to expel these young people who want to staff our labs, or start new businesses, or defend our country simply because of the actions of their parents — or because of the inaction of politicians,” Obama said.
Excitement among immigration rights advocates ensued and hundreds of young people swarmed the White House to rally in support of the president’s action. And this praise was echoed by LGBT rights advocates.
Rea Carey, executive director of the National Gay & Lesbian Task Force, was among those who praised the move.
“We applaud the Obama administration for taking this monumental and inspiring step,” Carey said. “It shows true leadership. It is heartening to know that hundreds of thousands of young people will no longer have to live in daily fear of being forced out of the country, away from the life and dreams they have built.”
But the policy change marks a turnabout for the administration, which had previously stated it wanted legislative action on the DREAM Act as opposed to pursuing executive action.
In September remarks before the Congressional Hispanic Caucus Institute’s annual gala, Obama talked about wanting Congress to take action on the DREAM Act
“I wish I had a magic wand and could make this all happen on my own,” Obama said. “There are times where — until Nancy Pelosi is speaker again — I’d like to work my way around Congress. But the fact is, even as we work towards a day when I can sign an immigration bill, we’ve got laws on the books that have to be upheld.”
To be fair, Obama didn’t completely rule out executive action on the DREAM Act at the gala. Saying “how we enforce those laws is also important,” the president noted the Department of Homeland Security is taking common-sense steps for immigration enforcement.
But the remarks should ring a bell. They’re along the lines of similar talking points that administration officials have expressed in regard to actions sought by the LGBT community. Now that the administration has taken action to help young, undocumented immigrants, will it reconsider its position on those other actions?
Perhaps the most high-profile outstanding request of the administration is an executive order requiring contractors doing business with the federal government to have employment non-discrimination policies inclusive of sexual orientation and gender identity. In April, the White House announced it wouldn’t take such action at this time and was opting instead for a legislative solution.
Felipe Matos, GetEQUAL’s national field director and a gay, undocumented immigrant, said last week following the announcement that he’s happy with Obama’s action, but wants to see more efforts on employment non-discrimination.
“I’m still reeling from the news and overjoyed by the announcement — but my heart has just enough room in it for another executive order,” Matos said. “It’s my hope that President Obama will make today especially historic by signing another executive order — one that will guarantee that I have the right to work freely and openly as an immigrant, but also as a gay American.”
Questions about why Obama chose to take administrative action on the immigration issue and not on the issue of LGBT workplace discrimination were asked even in Republican circles.
Richard Grenell, who’s gay and was briefly a foreign policy spokesperson for the Romney campaign, criticized Obama following the immigration announcement — reiterating a previously stated belief that Obama is playing politics with the LGBT community.
“President Obama obviously made a calculated political move to NOT give an executive order for ENDA,” Grenell said in an email to the Blade. “It’s painfully evident that the president doesn’t think gays are equal, he just thinks they are his solid and sure voting bloc and will treat us in raw political terms. Both parties, sadly, play politics with an issue that is about equality.”
For his part, Romney is facing his own political problems as a result of the DREAM Act administrative action. While taking a hard line on immigration during the Republican primary and saying he’d veto the DREAM Act, Romney has refused to say following Obama’s move whether he’d undo the action if elected president.
Despite these calls, the administration hasn’t changed its line on LGBT employment non-discrimination policy in the wake of the immigration policy.
Shin Inouye, a White House spokesperson, said nothing has changed in the administration’s position, reiterating that the directive won’t happen “at this time.”
“As has been previously stated, while it is not our usual practice to discuss executive orders that may or may not be under consideration, an order on LGBT non-discrimination for federal contractors will not be issued at this time,” Inouye said.
Another request of the administration is meant to protect bi-national same-sex couples from separation. Straight Americans can marry their foreign spouses to protect from deportations, but the same option isn’t available to gay Americans because of DOMA.
LGBT immigration rights groups have been asking the Department of Homeland Security to hold in abeyance the marriage-based green card applications for foreign nationals in same-sex relationships. The administration has said consistently in response to requests for this action that it plans to continue to enforce DOMA while it’s on the books.
Rachel Tiven, executive director of Immigration Equality, called the immigration announcement “great news for our country” and said it would protect gay foreign nationals in same-sex couples if they qualify for relief under the DREAM Act. Still, she called for additional action.
“No person should face forcible separation from their families, regardless of their age,” Tiven said. “That is why the White House should follow today’s announcement with a proposal to extend that same relief to immigrants with U.S.-citizen partners and spouses across the board. Keeping families together is good policy, and all families, including those that are LGBT, should have the support of the president in the form of a similar policy.”
Lavi Soloway, co-founder of Stop the Deportations, said he celebrates the move but wants additional action from the administration for bi-national couples in the wake of decisions from six federal courts finding DOMA unconstitutional.
“Every day these couples worry that they will be torn apart or forced into exile in order to stay together,” Soloway said. “This administration has said that denying green cards to the spouses of gay and lesbian Americans is a violation of the equal protection guarantee of the U.S. Constitution, but has not taken the steps necessary to mitigate the discriminatory impact of DOMA in this area.”
The actions that Soloway is seeking are: ordering an immediate moratorium on deportations of the foreign partners of gay Americans; providing temporary parole to the partners, spouses and children of gay Americans who are stuck outside the United States so that these families can be reunited; and putting on hold all “green card” petitions filed by gay Americans for their spouses.
Peter Boogard, a DHS spokesperson, reiterated that it will continue to enforce DOMA when asked about holding marriage-based green cards in abeyance.
“Pursuant to the attorney general’s guidance, the Defense of Marriage Act remains in effect and the executive branch, including the Department of Homeland Security, will continue to enforce it unless and until Congress repeals it, or there a final judicial determination that it is unconstitutional,” Boogard said.
But recent news may be an indication that the Obama administration is changing its tune. In recent weeks, the Board of Immigration Appeals has rejected the denial of green card petitions issued by U.S. Citizenship and Immigration Services in the cases filed by four married, gay couples who live in in Florida, New York, Pennsylvania and Canada.
In all cases, the BIA ordered the USCIS to conduct further inquiry to determine if these marriages are legally valid and whether if not for DOMA, the spouse would qualify for a green card.
In one case, the ruling re-opened removal proceedings for the spouse of a gay American who is facing an outstanding deportation order. According to Soloway, who’s handling the cases, the Board of Immigration Appeals has never before re-opened removal proceedings or remanded green card petitions back to USCIS after denials based solely on DOMA.
The Justice Department didn’t immediately respond to a request for comment.
LGBT advocates say they’ll continue to press forward. Speaking with the Washington Blade earlier this week, Chad Griffin, the new president of the Human Rights Campaign, commended Obama for taking action on immigration and said HRC will push forward when asked about these LGBT-related issues.
“HRC has been supportive of the DREAM Act for a long time,” Griffin said. “The president made an important step recently in the last week in what he announced and we have more to accomplish on some things that HRC will continue to voice our concern on.”
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
